The global EBER Probe market size is predicted to grow from US$ 102 million in 2025 to US$ 167 million in 2032; it is expected to grow at a CAGR of 7.3% from 2026 to 2032.

EBER probes are nucleic acid probes used for in situ hybridization (ISH) to detect Epstein-Barr virus (EBV)-encoding small RNAs (EBER1/2). They are commonly used in FFPE tissue sections for nucleus staining/fluorescence localization, aiding in the determination of latent EBV infection and related tumor subtyping.

Upstream: Oligonucleotide/probe design and synthesis, labeling (DIG/biotin/fluorescence), enzymes and buffers, slides and mounting materials. Downstream: Hospital pathology departments and third-party testing, tumor/lymphoma and nasopharyngeal carcinoma diagnosis, transplant follow-up, and research institutions.

In 2025, the global unit price of EBER probes was $619, with sales of 169,000 units and a global annual production capacity of 180,000 units. The industry profit margin was 25-30%.

Global Market Trends:

Clinical demand for refined subtyping of EBV-related diseases is increasing. EBER-ISH, due to its ability to locate infected cells at the tissue level, will remain a key detection method; its penetration rate continues to increase in the management of lymphoma, nasopharyngeal carcinoma, and immunosuppression-related diseases.

Platforms are accelerating automation and standardization: More laboratories are adopting ready-to-use probes and reagents compatible with mainstream fully automated IHC/ISH platforms, improving throughput, repeatability, and turnaround time, driving growth in demand for related consumables and service-oriented testing.

Technology is evolving towards the integration of multiplex RNA-ISH and digital pathology: Achieving spatial resolution of multiple targets/combined IHC on the same slide, coupled with high-resolution imaging and algorithmic quantification, will promote companion diagnostics and remote consultations; simultaneously, influenced by stricter IVD compliance and quality control requirements, manufacturers will place greater emphasis on sensitivity, specificity, and batch-to-batch consistency.

Infinity Market Research newest research report, the EBER Probe Industry Forecast looks at past sales and reviews total world EBER Probe sales in 2025, providing a comprehensive analysis by region and market sector of projected EBER Probe sales for 2026 through 2032. With EBER Probe sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world EBER Probe industry.

This Insight Report provides a comprehensive analysis of the global EBER Probe landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on EBER Probe portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global EBER Probe market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for EBER Probe and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global EBER Probe.

This report presents a comprehensive overview, market shares, and growth opportunities of EBER Probe market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    RNA Probe
    DNA Probe
    Segmentation by Probe Labeling:
    DIG-labeled Probes
    Biotin-labeled Probes
    Direct Fluorescent-labeled Probes
    Segmentation by Product Forms:
    Ready-to-use
    Concentrated

Segmentation by Application:

    Hospital
    Clinic
    Research Institutions
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Leica Biosystems
    Agilent
    Roche Diagnostics GmbH
    BioGenex
    Biosystems Switzerland AG
    ZytoVision GmbH
    Ngaio Diagnostics
    Biolynx
    Dartmon
    Celnovte Biotechnology
    DIAGLOGIC BIOLABS
    WuXi Diagnostics Lab (Shanghai)
    Xiamen Talent Biomedical Technology

Key Questions Addressed in this Report

What is the 10-year outlook for the global EBER Probe market?
What factors are driving EBER Probe market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do EBER Probe market opportunities vary by end market size?
How does EBER Probe break out by Type, by Application?